Fosun Pharma's HLX3902 Injection Receives First-Global Clinical Trial Approval in Australia
May 21, 2026 16:48
CST Updated
17:32
Fosun Pharmaceutical
Healthcare Industry Group
Henlius
Innovative Biopharmaceutical Company